Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Direxion Daily S&P Biotech Bear 3X ETF (NY:LABD)

7.410 UNCHANGED

Delayed Quote Updated: 8:00 PM EDT, Oct 20, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	1,308
Open	7.410
Bid (Size)	7.400 (2,000)
Ask (Size)	7.560 (1,900)
Prev. Close	7.410
Today's Range	7.410 - 7.410
52wk Range	5.810 - 33.40
Shares Outstanding	129,160
Dividend Yield	3.83%

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

EXCLUSIVE: Beyond The Magnificent Seven — Direxion's Egilinsky Reveals Top Sector Picks ↗

August 30, 2024

Direxion's Ed Egilinsky says there are several sectors could be impacted in the current rotation trade environment.

Via Benzinga

5 Inverse ETFs That Gained More Than 20% in April ↗

May 01, 2024

The U.S. stock market wrapped up April with losses, snapping a five-month winning streak and marking the market’s worst month of 2024.

Via Talk Markets

Performance

52-Week Range 77.8% below 52-week high

7.410

5.8152W Low 33.4052W High

1 Week 18.0% below 1-week high

7.291W Low 9.031W High

Direxion Daily S&P Biotech Bear 3X ETF (LABD) traded between $5.81 and $33.40 over the past 52 weeks and last traded at $7.41, 77.8% below its 52-week high. Over the past week it ranged between $7.29 and $9.03.

Past 12 Months

-14.2%

+4.4%

-8.7%

-44.0%

-65.2%

-75.5%

1W -$1.23

1M +$0.31

3M -$0.71

6M -$5.83

YTD -$13.88

1Y -$22.86

LABD was -75.5% over the past year, -44.0% over six months, -65.2% year to date, -14.2% in the last week.

12 Months vs Market

LABD

-75.5%

DIA

+12.3%

SPY

+14.6%

QQQ

+17.3%

IWM

+11.1%

Over the past 12 months LABD returned -75.5% versus DIA (Dow) +12.3%, SPY (S&P 500) +14.6%, QQQ (Nasdaq 100) +17.3% and IWM (Russell 2000) +11.1%.

Volume & Liquidity 0.00× 3-mo avg

Today 1,308 3-mo avg 18.9M

23.2M

26.0M

18.9M

13.9M

YTD

10.4M

8.8M

LABD most recently traded 1,308 shares against a 3-month average daily volume of 18.9M.

More News

5 Leveraged/Inverse ETFs That Gained More Than 40% In Q3 ↗

October 02, 2023

Via Talk Markets

5 Inverse ETFs That Gained In Double Digits In August ↗

September 03, 2023

Via Talk Markets

Inverse ETFs Soar as Market Turns Sour ↗

August 09, 2023

Via Talk Markets

Want Diversified Upside in Biotechnology? Check out LABU

March 22, 2023

Via MarketBeat

5 Best Inverse-Leveraged ETFs Of February ↗

March 01, 2023

Via Talk Markets

Stocks See Worst Day in 2 Years: Inverse ETFs Shine ↗

May 19, 2022

Via Talk Markets

5 Inverse ETFs Enjoying A Rally This Year ↗

April 19, 2022

Via Talk Markets

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

December 07, 2021

Via InvestorPlace

5 Leveraged/Inverse ETFs Up More Than 15% in November ↗

December 02, 2021

Via Talk Markets

7 Inverse ETFs Riding High on Nasdaq Sell-Off ↗

May 11, 2021

Via Talk Markets

Frequently Asked Questions

Is Direxion Daily S&P Biotech Bear 3X ETF publicly traded?

Yes, Direxion Daily S&P Biotech Bear 3X ETF is publicly traded.

What exchange does Direxion Daily S&P Biotech Bear 3X ETF trade on?

Direxion Daily S&P Biotech Bear 3X ETF trades on the New York Stock Exchange

What is the ticker symbol for Direxion Daily S&P Biotech Bear 3X ETF?

The ticker symbol for Direxion Daily S&P Biotech Bear 3X ETF is LABD on the New York Stock Exchange

What is the current price of Direxion Daily S&P Biotech Bear 3X ETF?

The current price of Direxion Daily S&P Biotech Bear 3X ETF is 7.410

When was Direxion Daily S&P Biotech Bear 3X ETF last traded?

The last trade of Direxion Daily S&P Biotech Bear 3X ETF was at 10/20/26 08:00 PM ET

What is the market capitalization of Direxion Daily S&P Biotech Bear 3X ETF?

The market capitalization of Direxion Daily S&P Biotech Bear 3X ETF is 957.08K

How many shares of Direxion Daily S&P Biotech Bear 3X ETF are outstanding?

Direxion Daily S&P Biotech Bear 3X ETF has 957K shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.